Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases

A catalogue of splice junction sequences

Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,742

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498

Mechanisms of Alternative Pre-Messenger RNA Splicing

Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142

Messenger-RNA-binding proteins and the messages they carry

Dreyfuss, G., Kim, V. N., & Kataoka, N. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm760 · Cited by 1,457

Pre-mRNA splicing and human diseasePreprint

Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,248

Alternative splicing: increasing diversity in the proteomic world

Graveley, B. R. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(00)02176-4 · Cited by 1,228

Exon Recognition in Vertebrate Splicing

Berget, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2411 · Cited by 1,090

Sorting out the complexity of SR protein functions

Graveley, B. R. (2000) · RNA · doi:10.1017/s1355838200000960 · Cited by 1,080

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Pathology of Neurodegenerative Diseases

Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665

Tau and tauopathies

Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609

Alternative splicing and disease

Tazi, J., Bakkour, N., & Stamm, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.017 · Cited by 569

Phase separation and neurodegenerative diseases: a disturbance in the force

Zbinden, A., Pérez-Berlanga, M., De Rossi, P., & Polymenidou, M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.014 · Cited by 500

An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons

Agholme, L., Lindström, T., Kågedal, K., Marcusson, J. O., & Hallbeck, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091363 · Cited by 514

Microtubule-associated protein tau in development, degeneration and protection of neurons

Wang, J., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 405

The complexity of tau in Alzheimer’s disease

Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 393

Tau exon 10 alternative splicing and tauopathies

Liu, F., & Gong, C.-X. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-8 · Cited by 323

Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.-L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., et al. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.207 · Cited by 300

Role of tau protein in Alzheimer’s disease: The prime pathological player

Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability

Alonso, A. D., Cohen, L. S., Corbo, C., Morozova, V., ElIdrissi, A., Phillips, G., & Kleiman, F. E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00338 · Cited by 278

Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases

Kanaan, N. M., Morfini, G. A., LaPointe, N. E., Pigino, G. F., Patterson, K. R., Song, Y., Andreadis, A., Fu, Y., Brady, S. T., & Binder, L. I. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0560-11.2011 · Cited by 273

Splicing Regulation in Neurologic Disease

Licatalosi, D. D., & Darnell, R. B. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.017 · Cited by 250

The role of the LRRK2 gene in Parkinsonism

Li, J.-Q., Tan, L., & Yu, J.-T. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-47 · Cited by 249

Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation

Saito, T., Mihira, N., Matsuba, Y., Sasaguri, H., Hashimoto, S., Narasimhan, S., Zhang, B., Murayama, S., Higuchi, M., Lee, V. M. Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009487 · Cited by 248

Structural Principles of Tau and the Paired Helical Filaments of Alzheimer's Disease

Mandelkow, E., Von Bergen, M., Biernat, J., & Mandelkow, E. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00053.x · Cited by 243

Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients

Mertens, J., Herdy, J. R., Traxler, L., Schafer, S. T., Schlachetzki, J. C. M., Böhnke, L., Reid, D. A., Lee, H., Zangwill, D., Fernandes, D. P., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.004 · Cited by 240

Atypical, non-standard functions of the microtubule associated Tau protein

Sotiropoulos, I., Galas, M., Silva, J. M., Skoulakis, E. M. C., Wegmann, S., Maina, M. B., Blum, D. L., Sayas, C. L., Mandelkow, E., Mandelkow�, E., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0489-6 · Cited by 221

The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein

Kouprina, N., Pavlı́ček, A., Collins, N. K., Nakano, M., Noskov, V. N., Ohzeki, J., Mochida, G. H., Risinger, J. I., Goldsmith, P. K., Gunsior, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi220 · Cited by 210

It’s all about tau

Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 207

Regulation of human MAPT gene expression

Caillet‐Boudin, M., Buée, L., Sergeant, N., & Lefebvre, B. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0025-8 · Cited by 213

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

Colin, M., Dujardin, S., Schraen-Maschke, S., Meno-Tetang, G., Duyckaerts, C., Courade, J.-P., & Buée, L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02087-9 · Cited by 187

Tau isoform regulation is region‐ and cell‐specific in mouse brain

McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., & D'Souza, I. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21867 · Cited by 179

Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease

d’Errico, P., & Meyer‐Luehmann, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00265 · Cited by 191

Cytoskeletal pathologies of Alzheimer disease

Bamburg, J. R., & Bloom, G. S. (2009) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20388 · Cited by 175

The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy

Eckermann, K., Mocanu, M.-M., Khlistunova, I., Biernat, J., Nissen, A., Hofmann, A., Schönig, K., Bujard, H., Haemisch, A., Mandelkow, E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705282200 · Cited by 168

Nuclear Tau and Its Potential Role in Alzheimer’s Disease

Bukar Maina, M., Al-Hilaly, Y., & Serpell, L. (2016) · Biomolecules · doi:10.3390/biom6010009 · Cited by 161

GSK3β and tau protein in Alzheimer's disease and epilepsy

Toral-Rios, D., Pichardo-Rojas, P. S., Alonso-Vanegas, M., & Campos-Peña, V. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00019 · Cited by 158

Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158

Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons

Konzack, S., Thies, E., Marx, A., Mandelkow, E., & Mandelkow�, E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0927-07.2007 · Cited by 165

The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2‐BETA1 changes in sporadic Alzheimer's disease

Glatz, D. C., Rujescu, D., Tang, Y., Berendt, F. J., Hartmann, A. M., Faltraco, F., Rosenberg, C. K., Hulette, C., Jellinger, K., Hampel, H. J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03552.x · Cited by 145

The role of tau phosphorylation and cleavage in neuronal cell death

Chun, W. (2006) · Frontiers in bioscience · doi:10.2741/2097 · Cited by 144

The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

Buchholz, S., & Zempel, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13784 · Cited by 154

Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF65

Hastings, M. L., Allemand, E., Duelli, D. M., Myers, M. P., & Krainer, A. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000538 · Cited by 142

Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia

Stanwood, G. D., Leitch, D. B., Savchenko, V. L., Wu, J. Y., Fitsanakis, V. A., Anderson, D. J., Stankowski, J. N., Aschner, M., & McLaughlin, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06145.x · Cited by 136

Microglia in Alzheimer’s Disease in the Context of Tau Pathology

Perea, J. R., Bolós, M., & Ávila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 134

Tau as a Biomarker of Neurodegenerative Diseases

Schraen‐Maschke, S., Sergeant, N., Dhaenens, C., Bombois, S., Deramecourt, V., Caillet‐Boudin, M., Pasquier, F., Maurage, C., Sablonnière, B., Vanmechelen, E., et al. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.4.363 · Cited by 129

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies

Perea, J. R., Llorens-Martín, M., Ávila, J., & Bolós, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00172 · Cited by 129

RNA Helicase p68 (DDX5) Regulates tau Exon 10 Splicing by Modulating a Stem-Loop Structure at the 5′ Splice Site

Kar, A. N., Fushimi, K., Zhou, X., Ray, P., Chen, S., Chen, X., Liu, Z., Chen, S., & Wu, J. Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01149-10 · Cited by 132

Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams

Chaudhary, A. R., Berger, F., Berger, C. L., & Hendricks, A. G. (2018) · Traffic · doi:10.1111/tra.12537 · Cited by 118

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing

Corsi, A., Bombieri, C., Valenti, M. T., & Romanelli, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315383 · Cited by 118

Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges

Castellani, R. J., & Perry, G. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180721 · Cited by 110

Tau as a Biomarker of Neurodegeneration

Holper, S., Watson, R., & Yassi, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137307 · Cited by 121

Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles

Iqbal, K., Liu, F., & Gong, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.002 · Cited by 114

Glucose metabolism and AD: evidence for a potential diabetes type 3

González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112

Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons

Lacovich, V., Espíndola, S. L., Alloatti, M., Devoto, V. M. P., Cromberg, L. E., Čarná, M. E., Forte, G., Gallo, J., Bruno, L., Stokin, G. B., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2305-16.2016 · Cited by 108

Tau interactome and RNA binding proteins in neurodegenerative diseases

Kavanagh, T., Halder, A., & Drummond, E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00572-6 · Cited by 111

Regulation of alternative splicing of tau exon 10

Qian, W., & Liu, F. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1411-2 · Cited by 108

Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma

Chiasseu, M., Vargas, J. L. C., Destroismaisons, L., Velde, C. V., Leclerc, N. M., & Polo, A. D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3986-15.2016 · Cited by 105

Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons

Hergenreder, E., Minotti, A. P., Zorina, Y., Oberst, P., Zhao, Z., Munguba, H., Calder, E. L., Baggiolini, A., Walsh, R. M., Liston, C. M., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02031-z · Cited by 109

Pathological Changes of Tau Related to Alzheimer’s Disease

Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 106

Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A

Wu, Q., Liang, H., Shi, J., Jin, N., Grundke, I., Iqbal, K., Gong, C., & Liu, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr195 · Cited by 100

Transport and diffusion of Tau protein in neurons

Scholz, T., & Mandelkow�, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1610-7 · Cited by 105

Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy

Caillet‐Boudin, M., Fernández-Gómez, F.-J., Tran, H., Dhaenens, C., Buée, L., & Sergeant, N. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00057 · Cited by 107

Tau mis-splicing in the pathogenesis of neurodegenerative disorders

Park, S. A., Ahn, S. I., & Gallo, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.084 · Cited by 100

Modulating the Expression of Disease Genes with RNA-Based Therapy

Wood, M. J. A., Yin, H., & McClorey, G. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030109 · Cited by 98

The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s Disease

Dugger, B. N., Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T. L., Meechoovet, B., Reiman, E. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150859 · Cited by 93

Multigenic control of thyroid hormone functions in the nervous system

Nunez, J., Celi, F. S., Ng, L., & Forrest, D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.03.006 · Cited by 96

Biosensors for detection of Tau protein as an Alzheimer's disease marker

Ameri, M., Shabaninejad, Z., Movahedpour, A., Sahebkar, A., Mohammadi, S., Hosseindoost, S., Ebrahimi, M. S., Savardashtaki, A., Karimipour, M., & Mirzaei, H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.239 · Cited by 95

RNA-targeted splice-correction therapy for neuromuscular disease

Wood, M. J. A., Gait, M. J., & Yin, H. (2010) · Brain · doi:10.1093/brain/awq002 · Cited by 93

Astrocytes in Tauopathies

Reid, M. J., Beltran-Lobo, P., Johnson, L., Perez‐Nievas, B. G., & Noble, W. J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.572850 · Cited by 98

Loss of fused in sarcoma (FUS) promotes pathological Tau splicing

Orozco, D., Tahirović, S., Rentzsch, K., Schwenk, B. M., Haass, C., & Edbauer, D. (2012) · EMBO Reports · doi:10.1038/embor.2012.90 · Cited by 93

Tau alternative splicing in familial and sporadic tauopathies

Niblock, M., & Gallo, J. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120091 · Cited by 87

Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes

Lum, P. Y., Chen, Y., Zhu, J., Lamb, J. R., Melmed, S. K., Wang, S. S.-M., Drake, T. A., Lusis, A. J., & Schadt, E. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03661.x · Cited by 87

Glaucoma as Neurodegeneration in the Brain

Chan, J. W., Chan, N. C. Y., & Sadun, A. A. (2021) · Eye and Brain · doi:10.2147/eb.s293765 · Cited by 91

Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease

Cherry, J. D., Esnault, C. D., Baucom, Z., Tripodis, Y., Huber, B. R., Alvarez, V. E., Stein, T. D., Dickson, D. W., & McKee, A. C. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01189-4 · Cited by 85

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore, K. B. E., Hung, T.-J., & Fortin, J. S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103487 · Cited by 93

Misregulation of Alternative Splicing Causes Pathogenesis in Myotonic Dystrophy

Kuyumcu-Martinez, N. M., & Cooper, T. A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_7 · Cited by 83

Tau splicing and the intricacies of dementia

Andreadis, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22842 · Cited by 88

The MAPT H1 haplotype is associated with tangle-predominant dementia

Santa‐María, I., Haggiagi, A. M., Liu, X., Wasserscheid, J., Nelson, P. T., Dewar, K., Clark, L. N., & Crary, J. F. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1017-1 · Cited by 87

Tau binding to microtubules does not directly affect microtubule‐based vesicle motility

Morfini, G. A., Pigino, G. F., Mizuno, N., Kikkawa, M., & Brady, S. T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21154 · Cited by 84

A Soluble Oligomer of Tau Associated with Fiber Formation Analyzed by NMR

Peterson, D. W., Zhou, H., Dahlquist, F. W., & Lew, J. (2008) · Biochemistry · doi:10.1021/bi702466a · Cited by 76

Autophagic Pathways to Clear the Tau Aggregates in Alzheimer’s Disease

Gorantla, N. V., & Chinnathambi, S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00897-0 · Cited by 74

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration

Boyarko, B., & HOOK, V. Y. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.702788 · Cited by 81

Tau Exons 2 and 10, Which Are Misregulated in Neurodegenerative Diseases, Are Partly Regulated by Silencers Which Bind a SRp30c·SRp55 Complex That Either Recruits or Antagonizes htra2β1

Wang, Y., Wang, J., Gao, L., Lafyatis, R., Stamm, S., & Andreadis, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413846200 · Cited by 75

Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy

Sealey, M. A., Vourkou, E., Cowan, C. M., Bossing, T., Quraishe, S., Grammenoudi, S., Skoulakis, E. M. C., & Mudher, A. K. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.003 · Cited by 77

Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia

Andreadis, A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_5 · Cited by 72

Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties

Furukawa, Y., Kaneko, K., & Nukina, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248963 · Cited by 73

MicroRNAs and the Regulation of Tau Metabolism

Hébert, S. S., Sergeant, N., & Buée, L. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/406561 · Cited by 72

Phosphoregulation of Tau modulates inhibition of kinesin-1 motility

Stern, J. L., Lessard, D. V., Hoeprich, G. J., Morfini, G. A., & Berger, C. L. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-10-0728 · Cited by 69

Spectroscopic Approaches to the Conformation of Tau Protein in Solution and in Paired Helical Filaments

von Bergen�, M., Barghorn, S., Jeganathan�, S., Mandelkow, E., & Mandelkow, E. (2006) · Neurodegenerative Diseases · doi:10.1159/000095257 · Cited by 71

Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease

Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., & Ambasta, R. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140933 · Cited by 67

Complex Splicing and Neural Expression of Duplicated Tau Genes in Zebrafish Embryos

Chen, M., Martins, R. N., & Lardelli, M. T. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1145 · Cited by 67

CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease

Ladd, A. N. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.12.003 · Cited by 74

Variation in tau isoform expression in different brain regions and disease states

Majounie, E., Cross, W. C. H., Newsway, V., Dillman, A., Vandrovcová, J., Morris, C. M., Nalls, M. A., Ferrucci, L., Owen, M. J., O’Donovan, M. C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.017 · Cited by 65

Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy

Espíndola, S. L., Damianich, A., Alvarez, R. J., Sartor, M., Belforte, J. E., Ferrario, J. E., Gallo, J.-M., & Avale, M. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.079 · Cited by 65

Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy

Cherry, J. D., Kim, S. H., Stein, T. D., Pothast, M. J., Nicks, R., Meng, G., Huber, B. R., Mez, J., Alosco, M. L., Tripodis, Y., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12867 · Cited by 68

Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing

Dhaenens, C., Tran, H., Frandemiche, M., Carpentier, C., Schraen‐Maschke, S., Sistiaga, A., Goicoechea, M., Eddarkaoui, S., Brussel, E. V., Obriot, H., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.010 · Cited by 64

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies

Rodríguez-Martín, T., García-Blanco, M. A., Mansfield, S. G., Grover, A., Hutton, M. L., Yu, Q., Zhou, J., Anderton, B. H., & Gallo, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503150102 · Cited by 63

SRp54 (SFRS11), a Regulator for tau Exon 10 Alternative Splicing Identified by an Expression Cloning Strategy

Wu, J. Y., Kar, A., Kuo, D., Yu, B., & Havlioglu, N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00739-06 · Cited by 64

Molecular Chaperones and Regulation of Tau Quality Control: Strategies for Drug Discovery in Tauopathies

Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64

ETR‐3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I

Leroy, O., Dhaenens, C., Schraen‐Maschke, S., Bélarbi, K., Delacourte, A., Andreadis, A., Sablonnière, B., Buée, L., Sergeant, N., & Caillet‐Boudin, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20980 · Cited by 63

Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia

Sundar, P. D., Yu, C., Sieh, W., Steinbart, E. J., Garruto, R. M., Oyanagi, K., Craig, U.-K., Bird, T. D., Wijsman, E. M., Galasko, D. R., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl463 · Cited by 63

Microtubule‐associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions

Souter, S., & Lee, G. S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22287 · Cited by 62

Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus

Bullmann, T., de Silva, R., Holzer, M., Mori, H., & Arendt, T. (2006) · Hippocampus · doi:10.1002/hipo.20255 · Cited by 62

Genetic, physiologic and ecogeographic factors contributing to variation in Homo sapiens: Homo floresiensis reconsidered

Richards, G. D. (2006) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2006.01179.x · Cited by 62

Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1

Leroy, O., Wang, J., Maurage, C., Parent, M., Cooper, T. A., Buée, L., Sergeant, N., Andreadis, A., & Caillet‐Boudin, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.12.003 · Cited by 62

Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A

Ding, S., Shi, J., Qian, W., Iqbal, K., Grundke, I., Gong, C., & Liu, F. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.021 · Cited by 60

Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property

Liu, K., Liu, Y., Li, L., Qin, P., Iqbal, J., Deng, Y., & Qing, H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.002 · Cited by 62

Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia

Andreadis, A. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_5 · Cited by 72

Tau splicing and the intricacies of dementia

Andreadis, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22842 · Cited by 88

S3–03–04: Modulation of tau dys/function by regulated alternative splicing

Andreadis, A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.177

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing

Corsi, A., Bombieri, C., Valenti, M. T., & Romanelli, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315383 · Cited by 118

Tau mis-splicing in the pathogenesis of neurodegenerative disorders

Park, S. A., Ahn, S. I., & Gallo, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.084 · Cited by 100